Axxima Pharmaceuticals Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $17.8M
Latest Deal Amount
  • Investors
  • 1

Axxima Pharmaceuticals General Information

Description

Developer of antibiotic and antiviral drugs. The company develops small molecule compounds that block signal transduction pathways required by pathogens for their survival.

Contact Information

Website
www.axxima.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • Am Klopfersitz 19
  • Martinsried
  • 82152 Munich
  • Germany
+49 089 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Axxima Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 02-Mar-2005 $17.8M 000.00 Completed Bankruptcy: Admin/Reorg
6. Bankruptcy: Admin/Reorg 01-Dec-2004 Completed Bankruptcy: Admin/Reorg
5. Later Stage VC (Series D) 01-Jun-2004 0000 000.00 Completed Generating Revenue
4. Early Stage VC 19-Dec-2001 000.00 000.00 Completed Product Development
3. Grant 22-May-2001 00.000 000.00 Completed Product Development
2. Early Stage VC $28.1M $28.1M Completed Product Development
1. Early Stage VC Completed Product Development
To view Axxima Pharmaceuticals’s complete valuation and funding history, request access »

Axxima Pharmaceuticals Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bear Stearns Health InnoVentures Management Venture Capital Minority 000 0000 000000 0
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
Heidelberg Innovation Fonds Management Venture Capital Minority 000 0000 000000 0
LBBW Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »